Luke Goedeke

Left Guard

Age: 27
Free Agency: 2030 (UFA)
Accrued Seasons: 3
  • 2025 Salary Cap Charge: $2,379,652 (0.84% of cap)
  • 2025 Cash Payout: $5,406,000 (1.99% of spending)
  • 2025 Cash to Cap Ratio: 2.27
  • Contract Value: $90,000,000 ($22,500,000 APY)
  • Fully Guaranteed Money: $27,406,000
  • Contract Ranking: 2/78 at LG

Current Contract

(Extension, signed 2025)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated Signing BonusRoster BonusGuaranteed SalaryCap
Number
Cap %
Dead Money & Cap Savings
RegularPer Game
202527$1,100,000$1,279,652$4,306,000$0$1,100,000$2,379,6520.8%
2026 📝
March 17: 2027 salary is guaranteed & per game bonus
28$1,215,000$861,200$20,275,000$510,000$22,000,000$22,861,2007.3%
202729$21,490,000$861,200$0$510,000$0$22,861,2007.4%
202830$21,490,000$861,200$0$510,000$0$22,861,2007.0%
2029 📝
March 17: Roster bonus due
31$20,490,000$861,200$1,000,000$510,000$0$22,861,200--
Total$65,785,000$4,724,452$25,581,000$2,040,000$23,100,000$93,824,452

Contract Notes

Luke Goedeke signed a four year, $90 million extension with the Buccaneers. $49.4 million is guaranteed of which $27.4 million is fully guaranteed at signing. The new money guarantee is $45 million. Goedeke's 2025 and 2026 salaries are fully guaranteed. If on the roster on the 5th day of the 2026 league year, his $22 million salary for 2027 will be fully guaranteed. There are annual per game bonuses as part of the contract.

Cash Flows

- fully earned money
- unearned or partially earned money
$22.5M
$45M
$67.5M
$90M
20252026202720282029
Cash Due$2,000,000$22,000,000$22,000,000$22,000,000$22,000,000
Running Cash$2,000,000$24,000,000$46,000,000$68,000,000$90,000,000
Career Earnings: $4,631,397
Career APY: $1,543,799
Potential Earnings: $98,037,397
Total Guarantees: $30,770,671
Largest Cash Payment: $22,000,000 (2026)
Largest Cap Number: $22,861,200 (2026)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
BuccaneersDraftedExtended20224$6,178,986$1,544,747$3,364,671$4,631,39775.0%$1,543,799
BuccaneersExtensionActive20254$90,000,000$22,500,000$27,406,000$00.0%$0
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Buccaneers3$4,631,397$1,543,799$4,212,9450.0%$00.0%

Season History

YearTeamBase SalaryProrated BonusRoster BonusPer Game Roster BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2022Buccaneers$705,000$418,452$0$0$705,000$1,123,4520.5%$2,378,808
2023Buccaneers$985,863$418,452$0$0$985,863$1,404,3150.6%$985,863
2024Buccaneers$1,266,726$418,452$0$0$0$1,685,1780.7%$1,266,726
2025Buccaneers$1,100,000$1,279,652$4,306,000$0$1,100,000$2,379,6520.8%$5,406,000
2026Buccaneers$1,215,000$861,200$20,275,000$510,000$22,000,000$22,861,2007.3%$22,000,000
2027Buccaneers$21,490,000$861,200$0$510,000$0$22,861,2007.4%$22,000,000
2028Buccaneers$21,490,000$861,200$0$510,000$0$22,861,2007.0%$22,000,000
2029Buccaneers$20,490,000$861,200$1,000,000$510,000$0$22,861,200--$22,000,000
Total$68,742,589$5,979,808$25,581,000$2,040,000$24,790,863$98,037,397$98,037,397

Statistics

YearGames PlayedGames InactiveSnaps
InjuredHealthyOffenseSpecial
2022113143.0%8.3%
20231700100.0%15.1%
2024130479.4%14.9%
202520013.4%2.3%

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$644,000$22,500,000
Injury Adjusted$644,000$22,500,000
test
OTC Valuation $3M $5.9M $8.9M $11.8M $14.8M APY $4M $8M $12M $16M $20M $8,123,000 $6,000,000

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.